Skip to main content
Erschienen in: Japanese Journal of Ophthalmology 4/2015

01.07.2015 | Clinical Investigation

Increased choroidal blood flow velocity with regression of unilateral acute idiopathic maculopathy

verfasst von: Yuki Hashimoto, Wataru Saito, Michiyuki Saito, Kiriko Hirooka, Shohei Mori, Kousuke Noda, Susumu Ishida

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The pathogenesis of unilateral acute idiopathic maculopathy (UAIM) is unknown. The aim of this study was to quantitatively examine changes in choroidal circulation hemodynamics in patients with UAIM.

Methods

This was a retrospective observational case-series which included five eyes of four patients with UAIM. All UAIM eyes and the fellow eyes in remaining three patients were studied using laser speckle flowgraphy (LSFG) to evaluate the mean blur rate (MBR), a quantitative index of relative blood flow velocity. The changes in MBR between the initial visit and after 1 and 3 months were statistically analyzed. Subfoveal choroidal thickness was measured in three UAIM eyes by enhanced depth imaging optical coherence tomography.

Results

The mean logMAR value of best-corrected visual acuity in the UAIM eyes significantly improved (P = 0.04) with recovery of outer retinal morphology. The average MBR of the UAIM eyes significantly increased at 1 (+21.7 % baseline value; P = 0.003) and 3 months (+32.5 % baseline value; P = 0.001), whereas the fellow eyes did not show this tendency. The mean values of subfoveal choroidal thickness decreased with time (316.0 µm at baseline, 186.6 µm at 1 month, and 167.3 µm at 3 months).

Conclusions

These results reveal that there is a significant elevation of choroidal blood flow velocity and substantial reduction of choroidal thickness with regression of UAIM, suggesting that impaired choroidal circulation may be involved in the pathogenesis of UAIM.
Literatur
1.
Zurück zum Zitat Yannuzzi LA, Jampol LM, Rabb MF, Sorenson JA, Beyrer C, Wilcox LM Jr. Unilateral acute idiopathic maculopathy. Arch Ophthalmol. 1991;109:1411–6.PubMedCrossRef Yannuzzi LA, Jampol LM, Rabb MF, Sorenson JA, Beyrer C, Wilcox LM Jr. Unilateral acute idiopathic maculopathy. Arch Ophthalmol. 1991;109:1411–6.PubMedCrossRef
2.
Zurück zum Zitat Freund KB, Yannuzzi LA, Barile GR, Spaide RF, Milewski SA, Guyer DR. The expanding clinical spectrum of unilateral acute idiopathic maculopathy. Arch Ophthalmol. 1996;114:555–9.PubMedCrossRef Freund KB, Yannuzzi LA, Barile GR, Spaide RF, Milewski SA, Guyer DR. The expanding clinical spectrum of unilateral acute idiopathic maculopathy. Arch Ophthalmol. 1996;114:555–9.PubMedCrossRef
3.
Zurück zum Zitat Ghazi NG, Daccache A, Conway BP. Acute idiopathic maculopathy: report of a bilateral case manifesting a macular hole. Ophthalmology. 2007;114:e1–6.PubMedCrossRef Ghazi NG, Daccache A, Conway BP. Acute idiopathic maculopathy: report of a bilateral case manifesting a macular hole. Ophthalmology. 2007;114:e1–6.PubMedCrossRef
4.
Zurück zum Zitat Jung CS, Payne JF, Bergstrom CS, Cribbs BE, Yan J, Hubbard GB 3rd, et al. Multimodality diagnostic imaging in unilateral acute idiopathic maculopathy. Arch Ophthalmol. 2012;130:50–6.PubMedCentralPubMedCrossRef Jung CS, Payne JF, Bergstrom CS, Cribbs BE, Yan J, Hubbard GB 3rd, et al. Multimodality diagnostic imaging in unilateral acute idiopathic maculopathy. Arch Ophthalmol. 2012;130:50–6.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Beck AP, Jampol LM, Glaser DA, Pollack JS. Is coxsackievirus the cause of unilateral acute idiopathic maculopathy? Arch Ophthalmol. 2004;122:121–3.PubMedCrossRef Beck AP, Jampol LM, Glaser DA, Pollack JS. Is coxsackievirus the cause of unilateral acute idiopathic maculopathy? Arch Ophthalmol. 2004;122:121–3.PubMedCrossRef
6.
Zurück zum Zitat Matsushita E, Fukuda K, Nakahira A, Kishi S, Fukushima A. Resolution of photoreceptor outer segment damage in a patient with unilateral acute idiopathic maculopathy observed using spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2012;250:765–8.PubMedCrossRef Matsushita E, Fukuda K, Nakahira A, Kishi S, Fukushima A. Resolution of photoreceptor outer segment damage in a patient with unilateral acute idiopathic maculopathy observed using spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2012;250:765–8.PubMedCrossRef
7.
Zurück zum Zitat Haruta H, Sawa M, Saishin Y, Ohguro N, Tano Y. Clinical findings in unilateral acute idiopathic maculopathy: new findings in acute idiopathic maculopathy. Int Ophthalmol. 2010;30:199–202.PubMedCrossRef Haruta H, Sawa M, Saishin Y, Ohguro N, Tano Y. Clinical findings in unilateral acute idiopathic maculopathy: new findings in acute idiopathic maculopathy. Int Ophthalmol. 2010;30:199–202.PubMedCrossRef
8.
Zurück zum Zitat Srour M, Querques G, Rostaqui O, Souied EH. Early spectral-domain optical coherence tomography findings in unilateral acute idiopathic maculopathy. Retina. 2013;33:2182–4.PubMedCrossRef Srour M, Querques G, Rostaqui O, Souied EH. Early spectral-domain optical coherence tomography findings in unilateral acute idiopathic maculopathy. Retina. 2013;33:2182–4.PubMedCrossRef
9.
Zurück zum Zitat Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fujii H. Noncontact, two-dimensional measurement of retinal microcirculation using laser speckle phenomenon. Invest Ophthalmol Vis Sci. 1994;35:3825–34.PubMed Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fujii H. Noncontact, two-dimensional measurement of retinal microcirculation using laser speckle phenomenon. Invest Ophthalmol Vis Sci. 1994;35:3825–34.PubMed
10.
Zurück zum Zitat Sugiyama T, Araie M, Riva CE, Schmetterer L, Orgul S. Use of laser speckle flowgraphy in ocular blood flow research. Acta Ophthalmol. 2010;88:723–9.PubMedCrossRef Sugiyama T, Araie M, Riva CE, Schmetterer L, Orgul S. Use of laser speckle flowgraphy in ocular blood flow research. Acta Ophthalmol. 2010;88:723–9.PubMedCrossRef
11.
Zurück zum Zitat Aizawa N, Yokoyama Y, Chiba N, Omodaka K, Yasuda M, Otomo T, et al. Reproducibility of retinal circulation measurements obtained using laser speckle flowgraphy-NAVI in patients with glaucoma. Clin Ophthalmol. 2011;5:1171–6.PubMedCentralPubMed Aizawa N, Yokoyama Y, Chiba N, Omodaka K, Yasuda M, Otomo T, et al. Reproducibility of retinal circulation measurements obtained using laser speckle flowgraphy-NAVI in patients with glaucoma. Clin Ophthalmol. 2011;5:1171–6.PubMedCentralPubMed
12.
Zurück zum Zitat Isono H, Kishi S, Kimura Y, Hagiwara N, Konishi N, Fujii H. Observation of choroidal circulation using index of erythrocytic velocity. Arch Ophthalmol. 2003;121:225–31.PubMedCrossRef Isono H, Kishi S, Kimura Y, Hagiwara N, Konishi N, Fujii H. Observation of choroidal circulation using index of erythrocytic velocity. Arch Ophthalmol. 2003;121:225–31.PubMedCrossRef
13.
Zurück zum Zitat Hirose S, Saito W, Yoshida K, Saito M, Dong Z, Namba K, et al. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2008;86:902–7.PubMedCrossRef Hirose S, Saito W, Yoshida K, Saito M, Dong Z, Namba K, et al. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2008;86:902–7.PubMedCrossRef
14.
Zurück zum Zitat Hashimoto Y, Saito W, Mori S, Saito M, Ishida S. Increased macular choroidal blood flow velocity during systemic corticosteroid therapy in a patient with acute macular neuroretinopathy. Clin Ophthalmol. 2012;6:1645–9.PubMedCentralPubMed Hashimoto Y, Saito W, Mori S, Saito M, Ishida S. Increased macular choroidal blood flow velocity during systemic corticosteroid therapy in a patient with acute macular neuroretinopathy. Clin Ophthalmol. 2012;6:1645–9.PubMedCentralPubMed
15.
Zurück zum Zitat Saito M, Yoshida K, Saito W, Fujiya A, Ohgami K, Kitaichi N, et al. Astaxanthin increases choroidal blood flow velocity. Graefes Arch Clin Exp Ophthalmol. 2012;250:239–45.PubMedCrossRef Saito M, Yoshida K, Saito W, Fujiya A, Ohgami K, Kitaichi N, et al. Astaxanthin increases choroidal blood flow velocity. Graefes Arch Clin Exp Ophthalmol. 2012;250:239–45.PubMedCrossRef
16.
Zurück zum Zitat Saito M, Saito W, Hashimoto Y, Yoshizawa C, Fujiya A, Noda K, et al. Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy. Br J Ophthalmol. 2013;97:775–80.PubMedCrossRef Saito M, Saito W, Hashimoto Y, Yoshizawa C, Fujiya A, Noda K, et al. Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy. Br J Ophthalmol. 2013;97:775–80.PubMedCrossRef
17.
Zurück zum Zitat Saito M, Saito W, Hashimoto Y, Yoshizawa C, Shinmei Y, Noda K, et al. Correlation between decreased choroidal blood flow velocity and the pathogenesis of acute zonal occult outer retinopathy. Clin Experiment Ophthalmol. 2014;42:139–50.PubMedCrossRef Saito M, Saito W, Hashimoto Y, Yoshizawa C, Shinmei Y, Noda K, et al. Correlation between decreased choroidal blood flow velocity and the pathogenesis of acute zonal occult outer retinopathy. Clin Experiment Ophthalmol. 2014;42:139–50.PubMedCrossRef
18.
Zurück zum Zitat Hirooka K, Saito W, Noda K, Ishida S. Enhanced-depth imaging optical coherence tomography and laser speckle flowgraphy in a patient with acute macular neuroretinopathy. Ocul Immunol Inflamm. 2014;22:485–9.PubMedCrossRef Hirooka K, Saito W, Noda K, Ishida S. Enhanced-depth imaging optical coherence tomography and laser speckle flowgraphy in a patient with acute macular neuroretinopathy. Ocul Immunol Inflamm. 2014;22:485–9.PubMedCrossRef
19.
Zurück zum Zitat Riva CE, Titze P, Hero M, Petrig BL. Effect of acute decreases of perfusion pressure on choroidal blood flow in humans. Invest Ophthalmol Vis Sci. 1997;38:1752–60.PubMed Riva CE, Titze P, Hero M, Petrig BL. Effect of acute decreases of perfusion pressure on choroidal blood flow in humans. Invest Ophthalmol Vis Sci. 1997;38:1752–60.PubMed
20.
Zurück zum Zitat Okuno T, Sugiyama T, Kohyama M, Kojima S, Oku H, Ikeda T. Ocular blood flow changes after dynamic exercise in humans. Eye. 2006;20:796–800.PubMedCrossRef Okuno T, Sugiyama T, Kohyama M, Kojima S, Oku H, Ikeda T. Ocular blood flow changes after dynamic exercise in humans. Eye. 2006;20:796–800.PubMedCrossRef
21.
Zurück zum Zitat Maruko I, Iida T, Sugano Y, Oyamada H, Sekiryu T, Fujiwara T, et al. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina. 2011;31:510–7.PubMedCrossRef Maruko I, Iida T, Sugano Y, Oyamada H, Sekiryu T, Fujiwara T, et al. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina. 2011;31:510–7.PubMedCrossRef
22.
Zurück zum Zitat Takahashi A, Saito W, Hashimoto Y, Saito M, Ishida S. Impaired circulation in the thickened choroid of a patient with serpiginous choroiditis. Ocul Immunol Inflamm. 2014;22:409–13.PubMedCrossRef Takahashi A, Saito W, Hashimoto Y, Saito M, Ishida S. Impaired circulation in the thickened choroid of a patient with serpiginous choroiditis. Ocul Immunol Inflamm. 2014;22:409–13.PubMedCrossRef
23.
Zurück zum Zitat Hirooka K, Saito W, Hashimoto Y, Saito M, Ishida S. Increased macular choroidal blood flow velocity and decreased choroidal thickness with regression of punctate inner choroidopathy. BMC Ophthalmol. 2014;14:73.PubMedCentralPubMedCrossRef Hirooka K, Saito W, Hashimoto Y, Saito M, Ishida S. Increased macular choroidal blood flow velocity and decreased choroidal thickness with regression of punctate inner choroidopathy. BMC Ophthalmol. 2014;14:73.PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Hirooka K, Saito W, Namba K, Takemoto Y, Mizuuchi K, Uno T, et al. Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol. 2015;253:609–17.PubMedCrossRef Hirooka K, Saito W, Namba K, Takemoto Y, Mizuuchi K, Uno T, et al. Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol. 2015;253:609–17.PubMedCrossRef
25.
Zurück zum Zitat Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology. 2010;117:1792–9.PubMedCrossRef Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology. 2010;117:1792–9.PubMedCrossRef
Metadaten
Titel
Increased choroidal blood flow velocity with regression of unilateral acute idiopathic maculopathy
verfasst von
Yuki Hashimoto
Wataru Saito
Michiyuki Saito
Kiriko Hirooka
Shohei Mori
Kousuke Noda
Susumu Ishida
Publikationsdatum
01.07.2015
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 4/2015
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-015-0380-6

Weitere Artikel der Ausgabe 4/2015

Japanese Journal of Ophthalmology 4/2015 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.